Verona Pharma (VRNA) PT Raised to $26 at BTIG following data
Tweet Send to a Friend
BTIG analyst Thomas Shrader raised the price target on Verona Pharma (NASDAQ: VRNA) to $26.00 (from $17.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
